Yuhan Corporation
Clinical trials sponsored by Yuhan Corporation, explained in plain language.
-
New lung cancer pill shows promise in Head-to-Head trial
Disease control CompletedThis Phase 3 trial tested a new targeted therapy, lazertinib, against the standard drug gefitinib in 393 people with advanced EGFR-mutated non-small cell lung cancer. The goal was to see if lazertinib could keep cancer from growing longer. Participants took either lazertinib or g…
Phase: PHASE3 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New bronchitis drug shows promise in large trial
Symptom relief CompletedThis Phase 3 trial tested a new drug called YHP2401 against two other drugs for acute bronchitis. 286 adults with cough and phlegm took one of the treatments for 7 days. The goal was to see if YHP2401 works better at reducing symptoms.
Phase: PHASE3 • Sponsor: Yuhan Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Healthy volunteers test two antibiotic versions for equivalence
Knowledge-focused CompletedThis study checked if two different versions of an antibiotic (amoxicillin/clavulanic acid) work the same in the body. 63 healthy adults took a single dose of each drug in a random order. The goal was to see if the levels of drug in the blood were similar enough to consider the d…
Phase: PHASE1 • Sponsor: Yuhan Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC